Network origin in Anita Woodring first degree
Entity | Entity type | Industry | |
---|---|---|---|
Parion Sciences, Inc.
Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Parion Sciences operates as a development-stage pharmaceutical company focused on the discovery and development of new treatments for serious diseases in multiple therapeutic areas. The firm's technology corrects defects in the innate defense of mucosal surfaces by developing inhibitors of the epithelial sodium channel (ENaC). The company was founded by Richard C. Boucher and is headquartered in Durham, NC.
4
| Private Company | Miscellaneous Commercial Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Anita Woodring via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Council for Entrepreneurial Development
Council for Entrepreneurial Development Miscellaneous Commercial ServicesCommercial Services Council for Entrepreneurial Development provides an interactive forum for entrepreneurs, investors, service professionals, academicians, researchers and public policy makers. Its services and programs include connections to capital, venture mentoring, and signature conferences empower member companies to go further. The company was founded in 1984 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The University of Texas at Austin | College/University | Doctorate Degree | |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Oncternal Oncology, Inc.
Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Go Therapeutics, Inc.
Go Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Go Therapeutics, Inc. manufactures and develops cancer therapeutics. The company was founded by Constantine Theodoropulos and is headquartered in Cambrige, MA. | Pharmaceuticals: Major | Director/Board Member | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
CYMABAY THERAPEUTICS, INC. | Biotechnology | Chairman | |
University of Wisconsin | College/University | Graduate Degree | |
The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
James Madison University | College/University | Undergraduate Degree | |
Yale University | College/University | Undergraduate Degree | |
The University of North Carolina at Charlotte | College/University | Corporate Officer/Principal | |
GRIFOLS, S.A. | Pharmaceuticals: Major | Corporate Officer/Principal | |
OCUPHIRE PHARMA, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
MedThink Communications, Inc.
MedThink Communications, Inc. Advertising/Marketing ServicesCommercial Services MedThink Communications, Inc. is a healthcare communications agency that provides full-service offerings with focus on scientific and promotional communications. It offers scientific platform development, publication planning and execution and expert engagement services. The company was founded by Scott Goudy in 2004 and is headquartered in Raleigh, NC. | Advertising/Marketing Services | Corporate Officer/Principal | |
Opus Genetics, Inc.
Opus Genetics, Inc. BiotechnologyHealth Technology Opus Genetics, Inc. is a gene therapy company that focuses on treating inherited retinal diseases. The company is based in Raleigh, NC, and leverages knowledge of the best science and the expertise of pioneers in ocular gene therapy to transparently drive transformative treatments to patients. The company has a unique model and purpose, and is backed by Foundation Fighting Blindness's venture arm, the RD Fund. Opus Genetics has wholly owned programs in numerous orphan retinal diseases, and its AAV-based gene therapy portfolio tackles some of the most neglected forms of inherited blindness while creating novel orphan manufacturing scale and efficiencies. The company was founded in 2021 by Benjamin R. Yerxa, Peter L. Ginsberg, Jason D. Menzo, Jean Bennett, Russell Kelley, Jean Bennett. Benjamin R. Yerxa has been the CEO since 2021. | Biotechnology | Chief Operating Officer | |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Sales & Marketing | |
GSK PLC | Pharmaceuticals: Major | Sales & Marketing | |
Old Dominion University | College/University | Masters Business Admin | |
Feldan Bio, Inc.
Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Feldan Bio, Inc. develops, produces and supplies recombinant proteins for therapeutic and research purposes. It specializes in cell culture products, cytokines, enzymes, receptors, clinical grade cytokines, and research proteins. The company was founded by Fran?ois-Thomas Michaud and Francois-Eric Lebeau in 2007 and is headquartered in Quebec, Canada. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
United States | 22 |
Canada | 3 |
Spain | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 16 |
Consumer Services | 8 |
Commercial Services | 4 |
Operational
Director/Board Member | 11 |
Corporate Officer/Principal | 7 |
Chief Operating Officer | 4 |
Chairman | 4 |
Undergraduate Degree | 3 |
Most connected contacts
Insiders | |
---|---|
Robert Wills | 13 |
Joseph Schachle | 11 |
Richard C. Boucher | 5 |
Paul Boucher | 2 |
- Stock Market
- Insiders
- Anita Woodring
- Company connections